The regenerative medicine market will see explosive growth in the next 5 years.
To meet the increasing demand for innovation in medicine, cells are being grown in bioreactors.
It’s predicted to reach $49B by 2028.
Numerous factors are driving growth.
They include an aging population and rising incidence of chronic conditions.
The market is diverse, spanning a wide range of medical applications.
Orthopedics
Bone and cartilage regeneration
Cardiology
Heart muscle regeneration
Ophthalmology
Corneal and retinal regeneration
Oncology
Immunotherapy and tissue regeneration
Neurology
Neural repair and regeneration
Dermatology
Skin regeneration and wound healing
But research is slow and expensive.
Scaling up production of cell therapies is complicated, and experimentation requires excessive amounts of time and resources.
Bioreactors are the answer – but production is falling short of expectations!
Our solution:
YAcc
We’re developing YAcc (Yield Accelerator), a digital twin that will help regenerative medicine companies increase production and become profitable.
